Upgrade to SI Premium - Free Trial

Apogee Therapeutics (APGE)

134.26 +0.18 (0.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 Apogee Therapeutics, For: Jul 14 Filed by: Dambkowski Carl July 16, 2026 8:00 PM - SEC Filing Form DEFM14A Apogee Therapeutics, July 13, 2026 5:15 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jul 08 Filed by: HENDERSON MICHAEL THOMAS July 10, 2026 8:00 PM - SEC Filing Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP July 8, 2026 12:59 PM - SEC Filing Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: T. Rowe Price Investment Management, Inc. July 8, 2026 11:30 AM - SEC Filing Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: FMR LLC July 8, 2026 10:11 AM - SEC Filing Form 4 Apogee Therapeutics, For: Jul 01 Filed by: Dambkowski Carl July 2, 2026 8:13 PM - SEC Filing Form PREM14A Apogee Therapeutics, For: Jul 02 July 2, 2026 5:24 PM - SEC Filing Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders July 2, 2026 5:35 AM - StreetInsider Form 144 Apogee Therapeutics, Filed by: Dambkowski Carl July 1, 2026 5:00 PM - SEC Filing Form DEFA14A Apogee Therapeutics, June 26, 2026 5:25 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 22 Filed by: Dambkowski Carl June 24, 2026 8:02 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 22 Filed by: HENDERSON MICHAEL THOMAS June 24, 2026 8:01 PM - SEC Filing Stifel Downgrades Apogee Therapeutics Inc (APGE) to Hold June 24, 2026 9:30 AM - StreetInsider Mizuho Downgrades Apogee Therapeutics Inc (APGE) to Neutral June 24, 2026 4:12 AM - StreetInsider Form SCHEDULE 13D/A Apogee Therapeutics, Filed by: Fairmount Funds Management LLC June 23, 2026 5:00 PM - SEC Filing TD Cowen Downgrades Apogee Therapeutics Inc (APGE) to Hold June 23, 2026 4:37 PM - StreetInsider Guggenheim Downgrades Apogee Therapeutics Inc (APGE) to Neutral June 23, 2026 8:16 AM - StreetInsider Apogee Therapeutics Inc (APGE) PT Raised to $135 at RBC Capital June 23, 2026 6:58 AM - StreetInsider UBS Downgrades Apogee Therapeutics Inc (APGE) to Neutral June 23, 2026 3:07 AM - StreetInsider Form DEFA14A Apogee Therapeutics, June 22, 2026 5:10 PM - SEC Filing Form 144 Apogee Therapeutics, Filed by: Dambkowski Carl June 22, 2026 4:49 PM - SEC Filing Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold June 22, 2026 3:44 PM - StreetInsider Craig-Hallum Downgrades Apogee Therapeutics Inc (APGE) to Hold June 22, 2026 12:31 PM - StreetInsider Wedbush Downgrades Apogee Therapeutics Inc (APGE) to Neutral June 22, 2026 10:56 AM - StreetInsider Form 144 Apogee Therapeutics, Filed by: HENDERSON MICHAEL THOMAS June 22, 2026 10:40 AM - SEC Filing Apogee Therapeutics, BitFuFu rise premarket; AbbVie gains after deal June 22, 2026 10:16 AM - StreetInsider Canaccord Downgrades Apogee Therapeutics Inc (APGE) to Hold June 22, 2026 9:10 AM - StreetInsider Form DEFA14A Apogee Therapeutics, June 22, 2026 7:46 AM - SEC Filing Form 8-K Apogee Therapeutics, For: Jun 18 June 22, 2026 7:45 AM - SEC Filing Form 8-K Apogee Therapeutics, For: Jun 17 June 22, 2026 7:23 AM - SEC Filing AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion June 22, 2026 7:01 AM - StreetInsider AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio June 22, 2026 7:00 AM - PR NewsWire Apogee Therapeutics (APGE) call put ratio 1.1 calls to 1 put into share price up before the bell June 22, 2026 6:22 AM - StreetInsider Form 4 Apogee Therapeutics, For: Jun 10 Filed by: HENDERSON MICHAEL THOMAS June 12, 2026 5:05 PM - SEC Filing Form 8-K Apogee Therapeutics, For: Jun 09 June 12, 2026 5:01 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Fairmount Funds Management LLC June 11, 2026 8:04 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Shah Nimish P June 11, 2026 8:04 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 09 Filed by: McKenna Mark C. June 11, 2026 8:03 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 09 Filed by: JONES WILLIAM A JR June 11, 2026 8:02 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Fox Jennifer A. June 11, 2026 8:02 PM - SEC Filing Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Bollinger Lisa June 11, 2026 8:00 PM - SEC Filing Apogee Therapeutics Inc (APGE) PT Raised to $97 at RBC Capital June 8, 2026 5:19 AM - StreetInsider Form 4 Apogee Therapeutics, For: Jun 03 Filed by: Dambkowski Carl June 5, 2026 8:00 PM - SEC Filing Apogee Therapeutics Inc (APGE) PT Lowered to $116 at Deutsche Bank June 3, 2026 7:14 AM - StreetInsider Apogee Therapeutics to Participate in Upcoming June Conferences May 28, 2026 4:01 PM - Globe NewsWire Apogee Therapeutics (APGE) July 70 puts active, share price down 5.7% May 27, 2026 2:50 PM - StreetInsider Apogee Therapeutics Inc (APGE) PT Lowered to $81 at Truist Securities May 27, 2026 12:39 PM - StreetInsider Form 8-K Apogee Therapeutics, For: May 26 May 27, 2026 6:41 AM - SEC Filing Form 8-K Apogee Therapeutics, For: May 27 May 27, 2026 6:38 AM - SEC Filing Apogee Therapeutics shares jump on $1.3B Blackstone deal May 27, 2026 6:36 AM - StreetInsider Apogee secures $1.3 billion financing deal with Blackstone for drug development May 27, 2026 6:31 AM - StreetInsider Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart May 27, 2026 6:31 AM - Globe NewsWire Apogee reports positive results from atopic dermatitis drug trial May 27, 2026 6:30 AM - StreetInsider Apogee reports positive Phase 2 results for atopic dermatitis drug May 27, 2026 6:30 AM - StreetInsider Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis May 27, 2026 6:30 AM - Globe NewsWire Apogee Therapeutics to report phase 2 trial data on May 27 May 26, 2026 4:01 PM - StreetInsider Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026 May 26, 2026 4:01 PM - Globe NewsWire Form 4 Apogee Therapeutics, For: May 13 Filed by: HENDERSON MICHAEL THOMAS May 15, 2026 8:00 PM - SEC Filing Apogee Therapeutics Inc (APGE) PT Raised to $120 at Jefferies May 14, 2026 9:56 AM - StreetInsider Form 144 Apogee Therapeutics, Filed by: HENDERSON MICHAEL THOMAS May 13, 2026 10:35 AM - SEC Filing Form 10-Q Apogee Therapeutics, For: Mar 31 May 11, 2026 7:21 AM - SEC Filing Form 8-K Apogee Therapeutics, For: May 11 May 11, 2026 7:10 AM - SEC Filing Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results May 11, 2026 7:00 AM - Globe NewsWire Form 4 Apogee Therapeutics, For: May 06 Filed by: Dambkowski Carl May 8, 2026 8:01 PM - SEC Filing Form 144 Apogee Therapeutics, Filed by: Dambkowski Carl May 6, 2026 4:25 PM - SEC Filing Form 4 Apogee Therapeutics, For: May 01 Filed by: Henderson Jane May 4, 2026 8:00 PM - SEC Filing Form 144 Apogee Therapeutics, Filed by: Henderson Jane May 1, 2026 4:46 PM - SEC Filing Rothschild Redburn Starts Apogee Therapeutics Inc (APGE) at Buy May 1, 2026 2:49 AM - StreetInsider Form DEFA14A Apogee Therapeutics, April 24, 2026 4:30 PM - SEC Filing Form ARS Apogee Therapeutics, For: Dec 31 April 24, 2026 4:25 PM - SEC Filing Apogee Therapeutics board to lose two directors in May April 24, 2026 4:22 PM - StreetInsider Form DEF 14A Apogee Therapeutics, For: Jun 09 April 24, 2026 4:20 PM - SEC Filing Form 8-K Apogee Therapeutics, For: Apr 21 April 24, 2026 4:16 PM - SEC Filing Full Article List